165 related articles for article (PubMed ID: 32252393)
1. PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation.
Cammisotto V; Pastori D; Nocella C; Bartimoccia S; Castellani V; Marchese C; Scavalli AS; Ettorre E; Viceconte N; Violi F; Pignatelli P; Carnevale R
Antioxidants (Basel); 2020 Apr; 9(4):. PubMed ID: 32252393
[TBL] [Abstract][Full Text] [Related]
2. Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
Pastori D; Nocella C; Farcomeni A; Bartimoccia S; Santulli M; Vasaturo F; Carnevale R; Menichelli D; Violi F; Pignatelli P;
J Am Coll Cardiol; 2017 Sep; 70(12):1455-1462. PubMed ID: 28911508
[TBL] [Abstract][Full Text] [Related]
3. PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36.
Qi Z; Hu L; Zhang J; Yang W; Liu X; Jia D; Yao Z; Chang L; Pan G; Zhong H; Luo X; Yao K; Sun A; Qian J; Ding Z; Ge J
Circulation; 2021 Jan; 143(1):45-61. PubMed ID: 32988222
[TBL] [Abstract][Full Text] [Related]
4. Nox2-mediated platelet activation by glycoprotein (GP) VI: Effect of rivaroxaban alone and in combination with aspirin.
Cammisotto V; Carnevale R; Nocella C; Stefanini L; Bartimoccia S; Coluccia A; Silvestri R; Pignatelli P; Pastori D; Violi F
Biochem Pharmacol; 2019 May; 163():111-118. PubMed ID: 30771281
[TBL] [Abstract][Full Text] [Related]
5. Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation: A post-hoc analysis from the ATHERO-AF cohort.
Pastori D; Ettorre E; Carnevale R; Nocella C; Bartimoccia S; Del Sordo E; Cammisotto V; Violi F; Pignatelli P;
Atherosclerosis; 2019 Oct; 289():195-200. PubMed ID: 31303312
[TBL] [Abstract][Full Text] [Related]
6. Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis.
Cammisotto V; Baratta F; Simeone PG; Barale C; Lupia E; Galardo G; Santilli F; Russo I; Pignatelli P
Antioxidants (Basel); 2022 Mar; 11(3):. PubMed ID: 35326219
[TBL] [Abstract][Full Text] [Related]
7. PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse Liver.
Demers A; Samami S; Lauzier B; Des Rosiers C; Ngo Sock ET; Ong H; Mayer G
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2517-25. PubMed ID: 26494228
[TBL] [Abstract][Full Text] [Related]
8. Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study.
Pastori D; Carnevale R; Nocella C; Bartimoccia S; Novo M; Cammisotto V; Piconese S; Santulli M; Vasaturo F; Violi F; Pignatelli P;
J Am Heart Assoc; 2018 Nov; 7(22):e009509. PubMed ID: 30571484
[TBL] [Abstract][Full Text] [Related]
9. PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention.
Paciullo F; Momi S; Gresele P
Thromb Haemost; 2019 Mar; 119(3):359-367. PubMed ID: 30605918
[TBL] [Abstract][Full Text] [Related]
10. The influence of subclinical hypothyroidism on serum lipid profile, PCSK9 levels and CD36 expression on monocytes.
Fazaeli M; Khoshdel A; Shafiepour M; Rohban M
Diabetes Metab Syndr; 2019; 13(1):312-316. PubMed ID: 30641718
[TBL] [Abstract][Full Text] [Related]
11. Platelet function and activation markers in primary hypercholesterolemia treated with anti-PCSK9 monoclonal antibody: A 12-month follow-up.
Barale C; Bonomo K; Frascaroli C; Morotti A; Guerrasio A; Cavalot F; Russo I
Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):282-291. PubMed ID: 31653513
[TBL] [Abstract][Full Text] [Related]
12. [Effect and mechanism of PCSK9 on lectin-like oxidized low-density lipoprotein receptor-1 mediated oxidized low-density lipoprotein uptake by THP-1 derived macrophages].
Bao HL; Liao FJ; Fang L; Zhong F; Liu W; Li JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 May; 47(5):367-373. PubMed ID: 31142080
[No Abstract] [Full Text] [Related]
13. Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study.
Simonen P; Stenman UH; Gylling H
Clin Sci (Lond); 2015 Sep; 129(5):439-46. PubMed ID: 25857271
[TBL] [Abstract][Full Text] [Related]
14. Different behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillation.
Cangemi R; Celestini A; Calvieri C; Carnevale R; Pastori D; Nocella C; Vicario T; Pignatelli P; Violi F
Heart; 2012 Jul; 98(14):1063-6. PubMed ID: 22628539
[TBL] [Abstract][Full Text] [Related]
15. LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism.
Carnevale R; Bartimoccia S; Nocella C; Di Santo S; Loffredo L; Illuminati G; Lombardi E; Boz V; Del Ben M; De Marco L; Pignatelli P; Violi F
Atherosclerosis; 2014 Nov; 237(1):108-16. PubMed ID: 25238217
[TBL] [Abstract][Full Text] [Related]
16. LDL-R promoting activity of peptides derived from human PCSK9 catalytic domain (153-421): design, synthesis and biochemical evaluation.
Alghamdi RH; O'Reilly P; Lu C; Gomes J; Lagace TA; Basak A
Eur J Med Chem; 2015 Mar; 92():890-907. PubMed ID: 25679794
[TBL] [Abstract][Full Text] [Related]
17. HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox".
Kohli P; Ganz P; Ma Y; Scherzer R; Hur S; Weigel B; Grunfeld C; Deeks S; Wasserman S; Scott R; Hsue PY
J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130349
[TBL] [Abstract][Full Text] [Related]
18. Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.
Urban D; Pöss J; Böhm M; Laufs U
J Am Coll Cardiol; 2013 Oct; 62(16):1401-8. PubMed ID: 23973703
[TBL] [Abstract][Full Text] [Related]
19. Relation between proprotein convertase subtilisin/kexin type 9 and directly measured low-density lipoprotein cholesterol.
Tecson KM; Panettiere-Kennedy KS; Won JI; Garg P; Olugbode O; McCullough PA
Proc (Bayl Univ Med Cent); 2017 Jan; 30(1):16-20. PubMed ID: 28127122
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipoprotein-associated phospholipase A2 is inversely correlated with proprotein convertase subtilisin-kexin type 9.
Constantinides A; Kappelle PJ; Lambert G; Dullaart RP
Arch Med Res; 2012 Jan; 43(1):11-4. PubMed ID: 22300679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
